Aster Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$174K Buy
+1,050
New +$245K 0.06% 253
2025
Q4
Sell
-22,542
Closed -$4.18M 1265
2025
Q3
$4.18M Buy
22,542
+2,477
+12% +$424K 2.11% 1
2025
Q2
$3.06M Sell
20,065
-3,503
-15% -$538K 0.69% 36
2025
Q1
$3.89M Buy
23,568
+20,188
+597% +$3.16M 0.72% 13
2024
Q4
$489K Sell
3,380
-7,146
-68% -$1.11M 0.19% 149
2024
Q3
$1.71M Buy
+10,526
New +$1.68M 0.37% 65

Other funds holding JNJ

Aster Capital Management's JNJ Position: Q1 2026 in Review

Aster Capital Management opened a new position in Johnson & Johnson (JNJ) in Q1 2026: 1,050 shares worth $174K. The stake represents 0.06% of the portfolio and ranks #253 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in JNJ as recently as Q3 2025.

Aster Capital Management first reported a position in JNJ in Q3 2024 and has held it in 6 quarters since. The position peaked at $4.18M in Q3 2025. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Aster Capital Management held 1,050 shares of Johnson & Johnson worth $174K as of Q1 2026.
  • Johnson & Johnson was a new Aster Capital Management position in Q1 2026.
  • Johnson & Johnson made up 0.06% of Aster Capital Management's portfolio in Q1 2026, its #253 holding.
  • Aster Capital Management first reported a position in Johnson & Johnson in Q3 2024 and has held it in 6 quarters since.
  • Aster Capital Management's Johnson & Johnson position peaked at $4.18M in Q3 2025.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.